T. Rowe Price Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20M Buy
928,751
+279,372
+43% +$6.03M ﹤0.01% 956
2025
Q1
$10.8M Buy
649,379
+28,369
+5% +$471K ﹤0.01% 1099
2024
Q4
$11.4M Sell
621,010
-38,954
-6% -$715K ﹤0.01% 1129
2024
Q3
$10.2M Sell
659,964
-260,122
-28% -$4M ﹤0.01% 1140
2024
Q2
$15M Sell
920,086
-3,079,464
-77% -$50M ﹤0.01% 1029
2024
Q1
$74M Sell
3,999,550
-1,178,959
-23% -$21.8M 0.01% 617
2023
Q4
$162M Sell
5,178,509
-51,652
-1% -$1.62M 0.02% 447
2023
Q3
$109M Sell
5,230,161
-783,753
-13% -$16.3M 0.02% 496
2023
Q2
$144M Buy
6,013,914
+1,463,008
+32% +$35M 0.02% 453
2023
Q1
$85.6M Buy
4,550,906
+271,652
+6% +$5.11M 0.01% 545
2022
Q4
$68.1M Sell
4,279,254
-612,094
-13% -$9.74M 0.01% 578
2022
Q3
$80M Buy
4,891,348
+197,633
+4% +$3.23M 0.01% 528
2022
Q2
$66.1M Sell
4,693,715
-285,221
-6% -$4.02M 0.01% 789
2022
Q1
$121M Sell
4,978,936
-4,507,325
-48% -$109M 0.01% 672
2021
Q4
$221M Buy
9,486,261
+53,717
+0.6% +$1.25M 0.02% 533
2021
Q3
$157M Sell
9,432,544
-766,287
-8% -$12.7M 0.01% 629
2021
Q2
$249M Buy
10,198,831
+1,844,820
+22% +$45M 0.02% 493
2021
Q1
$216M Buy
8,354,011
+476,186
+6% +$12.3M 0.02% 535
2020
Q4
$421M Sell
7,877,825
-2,659,313
-25% -$142M 0.04% 362
2020
Q3
$435M Sell
10,537,138
-804,648
-7% -$33.2M 0.05% 322
2020
Q2
$550M Sell
11,341,786
-486,119
-4% -$23.6M 0.07% 284
2020
Q1
$500M Sell
11,827,905
-1,413,109
-11% -$59.7M 0.08% 257
2019
Q4
$566M Buy
13,241,014
+3,064,861
+30% +$131M 0.07% 281
2019
Q3
$366M Buy
10,176,153
+2,638,760
+35% +$95M 0.05% 333
2019
Q2
$201M Buy
7,537,393
+179,737
+2% +$4.8M 0.03% 464
2019
Q1
$198M Buy
7,357,656
+501,519
+7% +$13.5M 0.03% 471
2018
Q4
$111M Buy
6,856,137
+3,667,519
+115% +$59.3M 0.02% 578
2018
Q3
$66.2M Buy
3,188,618
+2,668,132
+513% +$55.4M 0.01% 806
2018
Q2
$7.95M Sell
520,486
-267,582
-34% -$4.09M ﹤0.01% 1382
2018
Q1
$17.7M Sell
788,068
-24,559
-3% -$552K ﹤0.01% 1222
2017
Q4
$24.5M Sell
812,627
-1,273,970
-61% -$38.4M ﹤0.01% 1108
2017
Q3
$78.6M Sell
2,086,597
-1,372,667
-40% -$51.7M 0.01% 697
2017
Q2
$96.5M Sell
3,459,264
-1,130,607
-25% -$31.5M 0.02% 617
2017
Q1
$158M Sell
4,589,871
-1,068,426
-19% -$36.7M 0.03% 483
2016
Q4
$163M Sell
5,658,297
-1,060,824
-16% -$30.6M 0.03% 465
2016
Q3
$214M Sell
6,719,121
-396,158
-6% -$12.6M 0.04% 409
2016
Q2
$231M Sell
7,115,279
-875,038
-11% -$28.4M 0.05% 374
2016
Q1
$223M Buy
7,990,317
+2,395,602
+43% +$67M 0.05% 370
2015
Q4
$199M Buy
5,594,715
+3,051
+0.1% +$109K 0.04% 397
2015
Q3
$185M Sell
5,591,664
-40,850
-0.7% -$1.35M 0.04% 425
2015
Q2
$236M Sell
5,632,514
-424,909
-7% -$17.8M 0.05% 403
2015
Q1
$197M Sell
6,057,423
-183,375
-3% -$5.98M 0.04% 442
2014
Q4
$198M Sell
6,240,798
-292,545
-4% -$9.29M 0.04% 429
2014
Q3
$162M Buy
6,533,343
+570,880
+10% +$14.1M 0.04% 474
2014
Q2
$135M Buy
5,962,463
+3,178,943
+114% +$71.8M 0.03% 549
2014
Q1
$67.7M Buy
2,783,520
+186,575
+7% +$4.54M 0.02% 758
2013
Q4
$64.9M Buy
2,596,945
+729,355
+39% +$18.2M 0.01% 741
2013
Q3
$51.3M Buy
1,867,590
+482,390
+35% +$13.3M 0.01% 806
2013
Q2
$25.1M Buy
+1,385,200
New +$25.1M 0.01% 1007